Suppr超能文献

乳腺癌与甲状腺癌的关联:一项系统评价与荟萃分析

The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

作者信息

Nielsen Sarah M, White Michael G, Hong Susan, Aschebrook-Kilfoy Briseis, Kaplan Edwin L, Angelos Peter, Kulkarni Swati A, Olopade Olufunmilayo I, Grogan Raymon H

机构信息

Department of Medicine, Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois.

Endocrine Surgery Research Program, Department of Surgery, The University of Chicago Pritzker School of Medicine, Chicago, Illinois.

出版信息

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):231-8. doi: 10.1158/1055-9965.EPI-15-0833.

Abstract

Rates of thyroid cancer in women with a history of breast cancer are higher than expected. Similarly, rates of breast cancer in those with a history of thyroid cancer are increased. Explanations for these associations include detection bias, shared hormonal risk factors, treatment effect, and genetic susceptibility. With increasing numbers of breast and thyroid cancer survivors, clinicians should be particularly cognizant of this association. Here, we perform a systematic review and meta-analysis of the literature utilizing PubMed and Scopus search engines to identify all publications studying the incidence of breast cancer as a secondary malignancy following a diagnosis of thyroid cancer or thyroid cancer following a diagnosis of breast cancer. This demonstrated an increased risk of thyroid cancer as a secondary malignancy following breast cancer [OR = 1.55; 95% confidence interval (CI), 1.44-1.67] and an increased risk of breast cancer as a secondary malignancy following thyroid cancer (OR = 1.18; 95% CI, 1.09-1.26). There is a clear increase in the odds of developing either thyroid or breast cancer as a secondary malignancy after diagnosis with the other. Here, we review this association and current hypothesis as to the cause of this correlation.

摘要

有乳腺癌病史的女性患甲状腺癌的几率高于预期。同样,有甲状腺癌病史的人患乳腺癌的几率也会增加。对这些关联的解释包括检测偏倚、共同的激素风险因素、治疗效果和遗传易感性。随着乳腺癌和甲状腺癌幸存者数量的增加,临床医生应特别关注这种关联。在此,我们利用PubMed和Scopus搜索引擎对文献进行系统综述和荟萃分析,以识别所有研究在诊断甲状腺癌后作为继发性恶性肿瘤的乳腺癌发病率或在诊断乳腺癌后甲状腺癌发病率的出版物。这表明乳腺癌后作为继发性恶性肿瘤患甲状腺癌的风险增加[比值比(OR)=1.55;95%置信区间(CI),1.44 - 1.67],以及甲状腺癌后作为继发性恶性肿瘤患乳腺癌的风险增加(OR = 1.18;95%CI,1.09 - 1.26)。在被诊断患有另一种癌症后,作为继发性恶性肿瘤患甲状腺癌或乳腺癌的几率明显增加。在此,我们综述这种关联以及关于这种相关性原因的当前假说。

相似文献

1
The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):231-8. doi: 10.1158/1055-9965.EPI-15-0833.
2
Prognostic factors for return to work in breast cancer survivors.
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
3
Interventions for promoting habitual exercise in people living with and beyond cancer.
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
4
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
9
Interventions targeted at women to encourage the uptake of cervical screening.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
10
Nutritional interventions for survivors of childhood cancer.
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

引用本文的文献

2
4
Nongenetic risk factors for thyroid cancer: an umbrella review of evidence.
Endocrine. 2025 Apr;88(1):60-74. doi: 10.1007/s12020-024-04155-x. Epub 2025 Jan 2.
5
Comparative analysis through propensity score matching in thyroid cancer: unveiling the impact of multiple malignancies.
Front Endocrinol (Lausanne). 2024 Jun 4;15:1366935. doi: 10.3389/fendo.2024.1366935. eCollection 2024.
6
Second primary non-breast cancers in young breast cancer survivors.
Breast Cancer Res Treat. 2024 Oct;207(3):587-597. doi: 10.1007/s10549-024-07400-z. Epub 2024 Jun 10.
7
Risk of second primary thyroid cancer in cancer survivors.
Sci Rep. 2024 May 30;14(1):12478. doi: 10.1038/s41598-024-63155-z.
8
Thyroid Metastases from Breast Cancer Case Report and Literature Review.
Curr Cancer Drug Targets. 2025;25(1):83-95. doi: 10.2174/0115680096274465240129055950.
9
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer.
Breast Cancer (Dove Med Press). 2024 Jan 9;16:15-22. doi: 10.2147/BCTT.S442707. eCollection 2024.

本文引用的文献

1
Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies.
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1327-31. doi: 10.1158/1055-9965.EPI-15-0292. Epub 2015 Jul 9.
3
Korea's thyroid-cancer "epidemic"--screening and overdiagnosis.
N Engl J Med. 2014 Nov 6;371(19):1765-7. doi: 10.1056/NEJMp1409841.
5
Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
J Clin Oncol. 2014 Jun 10;32(17):1818-24. doi: 10.1200/JCO.2013.53.6656. Epub 2014 Apr 28.
7
Current thyroid cancer trends in the United States.
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. doi: 10.1001/jamaoto.2014.1.
8
Solid tumor second primary neoplasms: who is at risk, what can we do?
Semin Oncol. 2013 Dec;40(6):676-89. doi: 10.1053/j.seminoncol.2013.09.012.
9
Obesity as a major risk factor for cancer.
J Obes. 2013;2013:291546. doi: 10.1155/2013/291546. Epub 2013 Aug 29.
10
Second primary malignancies following thyroid cancer: a population-based study in Taiwan.
Eur J Endocrinol. 2013 Oct 1;169(5):577-85. doi: 10.1530/EJE-13-0309. Print 2013 Nov.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验